Cyclomedica News

USFDA Approval to File Received for Technegas™

27th May 2020

Continue Reading

Technegas™ approved in Russia

26th May 2020

Continue Reading

Clinical research opportunity in COVID-19

4th May 2020

Continue Reading

Register your interest to be the first to get Technegas™ in the USA

24th Apr 2020

Continue Reading

Cyclomedica Lodges NDA for Technegas™ with the USFDA

30th Mar 2020

Continue Reading

Technegas™ is not an aerosol generating procedure

23rd Mar 2020

Continue Reading

Technegas™ and Covid-19

20th Mar 2020

Continue Reading

Visit us at booth #878 – SNMMI 2019 Annual Meeting

19th Jun 2019

Continue Reading

Cyclomedica will exhibit at the German Annual Meeting of Nuclear Medicine

1st Mar 2019

Continue Reading

Cyclomedica will exhibit at the EANM 2019 congress

1st Mar 2019

Continue Reading

New Guidelines from the CANM

18th Jan 2019

Continue Reading

Cyclopharm (ASX:CYC) results of US FDA meeting

29th Oct 2018

Continue Reading

Cyclopharm (ASX:CYC) radiopharmaceutical leader

8th Oct 2018

Continue Reading

Our 4th million Patient Administration Set has been manufactured

31st May 2018

Continue Reading

New clinical trial to develop better tools for asthma and COPD

18th May 2018

Continue Reading

Copyright © Cyclomedica Europe 2020 | Last Updated: March 8, 2019 Privacy Policy